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Abstract
Recombination in enteroviruses provides an evolutionary mechanism for acquiring extensive regions of novel sequence, is
suggested to have a role in genotype diversity and is known to have been key to the emergence of novel neuropathogenic
variants of poliovirus. Despite the importance of this evolutionary mechanism, the recombination process remains relatively
poorly understood. We investigated heterologous recombination using a novel reverse genetic approach that resulted in
the isolation of intermediate chimeric intertypic polioviruses bearing genomes with extensive duplicated sequences at the
recombination junction. Serial passage of viruses exhibiting such imprecise junctions yielded progeny with increased fitness
which had lost the duplicated sequences. Mutations or inhibitors that changed polymerase fidelity or the coalescence of
replication complexes markedly altered the yield of recombinants (but did not influence non-replicative recombination)
indicating both that the process is replicative and that it may be possible to enhance or reduce recombination-mediated
viral evolution if required. We propose that extant recombinants result from a biphasic process in which an initial
recombination event is followed by a process of resolution, deleting extraneous sequences and optimizing viral fitness. This
process has implications for our wider understanding of ‘evolution by duplication’ in the positive-strand RNA viruses.
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Introduction
The high levels of genetic variation observed in many RNA
viruses has important consequences for viral pathogenesis, host
tropism and evolution. Two predominant mechanisms contribute
to the generation of genetic diversity of the genome; misincorpora-
tion of nucleotides and recombination/reassortment. The absence
of proofreading by the majority of viral RNA-dependent RNA-
polymerases (RdRp) results in error frequencies of 1023 to 1025
per nucleotide polymerized [1], so generating a population of
related genomes, the quasispecies [2]. In contrast to the
incremental changes (‘drift’) that accumulate from this misincor-
poration, much more extensive variation can result from exchange
or acquisition of large regions of the virus genome through the
processes of recombination or, in terms of genetic consequences
for the segmented RNA viruses, the analogous process of
reassortment.
The enteroviruses are a well characterised genus within the
family Picornaviridae. The human enteroviruses (HEV) are partic-
ularly well studied as they contain important pathogens respon-
sible for acute flaccid paralysis (including poliomyelitis), myocar-
ditis, encephalitis and a variety of other ailments [3] and have
recently been extended to include the three species of human
rhinoviruses [4]. The nonsegmented single-stranded positive-sense
enterovirus RNA genome is ,7.5 kb in length, is polyadenylated
at the 39 end and encodes a single polyprotein from an open
reading frame flanked by an extensive 59 and shorter 39 non-
coding region (NCR). The polyprotein is co- and post-transla-
tionally proteolytically processed to yield (in order of translation)
the viral structural (VP4, 2, 3 and 1; occupying the P1 region,
Figure 1) and non-structural proteins (2Apro, 2B, 2C, 3A, VPg,
3Cpro and 3Dpol; comprising the P2 and P3 regions of the
genome). The latter control the cellular environment, establish the
membrane-bound replication complex, replicate the genome via
formation of a negative-stranded intermediate and process the
polyprotein.
The HEV are divided into four phylogenetically distinct species
(designated A–D; [4]) the members of which were initially
differentiated serologically, and are now usually defined by
sequence analysis of VP1 [5–8]. Extensive sequencing studies
have unequivocally demonstrated the time-related accumulation
of sequence variation – and consequent antigenic diversification –
within the capsid-coding region [9–14] and frequent recombina-
tion within the regions encoding the non-structural proteins
[13,15–33]. Additional recombination events have been charac-
terised between the 59 NCR and capsid coding region [34,35].
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The HEV genome can therefore be considered as modular, with
recombination between the functional entities that drive transla-
tion and replication (59 NCR), that encode the structural proteins
(the P1 region) and that encode the non-structural proteins
[21,28]. Recombination within the P1 region has rarely been
observed, and only then between very closely related viruses or
involving the extreme termini of VP1, presumably due to
restrictions imposed on assembly of the icosahedral particle [36].
In contrast, in addition to the extensive documentation of
recombination within the non-structural protein coding region,
different serotypes exhibit distinct temporal and geographic
kinetics in the appearance of the predominant recombinant forms
(RF) [23–25] although the selection of emergent RFs, whether due
to replicative or immunological advantage, has yet to be
determined [25].
The majority of characterised HEV recombinants circulating
are intraspecies, though interspecies recombination may have
occurred in ancestral enteroviruses [37–40] and 59 NCR
exchanges constructed in the laboratory can generate viable
viruses [41,42]. The restrictions preventing viable interspecies
recombinants between structural and non-structural coding
regions are poorly understood. In addition to a requirement to
access the same cell type and co-occupy the same replication
complex [43], these presumably include the necessity for
compatibility in all cis-acting replication functions [44]. For
example, recent evidence indicates that particle morphogenesis
requires an interaction of the 2C protein and capsid protein VP3
[45,46].
Despite the importance of recombination as an evolutionary
process in enteroviruses, the molecular mechanism involved has
received relatively little attention. The favoured replicative
mechanism in enteroviruses (and other RNA viruses) involves
template-switching of the viral RdRp during negative strand RNA
synthesis [47–49]. An alternative process, involving the replica-
tion-independent joining of RNA molecules has been described by
Agol and colleagues [50,51] which may be mediated by cellular
RNA ligases as postulated for analogous studies in pestiviruses and
hepatitis C virus [52,53].
Studies of the viable recombinant progeny from cells co-infected
with enteroviruses are confounded by the relatively low frequency
with which recombinants are generated and the high levels of
parental viruses generally produced from such infections. Togeth-
er, this necessitates the use of a selection strategy to preferentially
isolate recombinants from a mixed population, which likely
imposes an additional selection for increased fitness within the
recombinant population. To overcome these limitations we have
developed an in vitro reverse genetic system that enables the
recovery of recombinants alone from dually transfected cells in
culture. We have used this to characterise the recombination
junctions and subsequently investigate the replication phenotype
and stability of the recovered viruses. Our studies suggest that
replicative (i.e. polymerase-dependent) recombination is a biphasic
process in which an initial chimeric genome is generated that
contains a duplication of up to several hundred nucleotides (nt.) of
the virus genome. Subsequent replication of these genomes results
in a process of resolution in which variants are selected that have
undergone an internal deletion to remove the duplicated
sequences, resulting in genomes of the expected (i.e. genomic)
length. These studies provide important insights into the molecular
mechanism of recombination in positive strand RNA viruses and
additionally suggest a means by which ‘evolution by duplication’
may occur. The novel experimental strategy we described provides
the basis for further studies of the viral and cellular processes that
control this important evolutionary process.
Results
A system for generating recombinant enteroviruses
To facilitate the analysis of recombination junctions and early
recombination events in enteroviruses we wanted an approach
that allowed the production of recombinants in the absence of
either replication-competent helper viruses or low frequency
revertants of parental genomes bearing genetic lesions such as
resistance to guanidine hydrochloride [45,54]. Since recombina-
tion is proposed to occur by a ‘copy-choice’ process involving
polymerase template switching during negative strand synthesis
[47] we reasoned that one of the parental genomes could be
defective in synthesis of positive-strands, a phenotype associated
with destabilization of the cis-acting replication element (CRE)
located within the 2C coding region of enteroviruses [55]. We
have previously demonstrated that a poliovirus genome bearing
eight synonymous substitutions within this CRE does not revert,
even after extensive blind passage [56,57]. For the second parental
genome we used a replication-competent sub-genomic replicon, in
which the capsid-coding region was replaced with a luciferase
reporter gene. The rationale was that co-transfection of RNA
generated in vitro from these two cDNAs should yield a complete,
replication competent genome – bearing both the capsid-coding
region and a functional CRE – if a recombination cross-over
occurred between the end of the capsid coding region and the
CRE (Figure 1a). The reciprocal recombinant – if generated –
bearing a luciferase reporter and non-functional CRE would not
replicate and neither parental genome was capable of generating
progeny virus. To facilitate the recovery of potential recombinants
that had not undergone successive rounds of release, re-infection
and replication, we used rodent cells – permissive for virus
replication but lacking a suitable receptor and so not susceptible to
infection – for transfection. This approach facilitated the capture
of early recombinant virus progeny whilst minimizing their loss
due to continued propagation. The generic recombination system
Author Summary
The rapid evolution of most positive-sense RNA viruses
enables them to escape immune surveillance and adapt to
new hosts. Genetic variation arises due to their error-prone
RNA polymerases and by recombination of viral genomes
in co-infected cells. We have developed a novel approach
to analyse the poorly understood mechanism of recombi-
nation using a poliovirus model system. We characterised
the initial viable recombinants and demonstrate the
majority are longer than genome length due to an
imprecise crossover event that duplicates part of the
genome. These viruses are unfit, but rapidly lose the
duplicated material and regain full fitness upon serial
passage, a process we term resolution. We show this is a
replicative recombination process by modifying the fidelity
of the viral polymerase, or replication complex coales-
cence, using methods that have no influence on a
previously reported, less efficient, non-replicative recom-
bination mechanism. We conclude that recombination is a
biphasic process involving separate generation and reso-
lution events. These new insights into an important
evolutionary mechanism have implications for our under-
standing of virus evolution through partial genome
duplication, they suggest ways in which recombination
might be modified and provides an approach that may be
exploited to analyse recombination in other RNA viruses.
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Figure 1. The CRE-REP assay to analyse recombination in enteroviruses. A) Schematic diagram of enterovirus recombination partners and
products. The upper panel shows a diagram of a genome (dark shading) bearing a defective CRE indicated as a broken line with a superimposed X in
the 2C-coding region and a luciferase-encoding replicon (light shading). Following co-transfection into permissive cells (indicated by an arrow), a
replication competent recombinant genome may be recovered of the generic structure shown, consisting of the 59 part of the genome derived from
the CRE-defective parent (the recipient) and the 39 part of the genome from the luciferase-encoding replicon (the donor). The graduated shading
between the 39 end of the VP1-coding region and the 2C CRE indicates the area within which recombination must occur to produce a functional
genome. B) Schematic diagram of the recombinant production strategy. RNA generated in vitro was co-transfected into cells permissive for virus
replication but not susceptible to infection. After 24–48 hours, supernatant virus was recovered, cloned by limit dilution and subjected to further
analysis. C) Xylene cyanol-stained HeLa cell monolayers infected with supernatant from murine L929 cells transfected with RNA derived from the
plasmids indicated. Guanidine hydrochloride (GuHCl; 4 mM) added where indicated to HeLa cells. D) Comparison of inter- and intra-serotypic
recombination following independent co-transfection of L929 murine fibroblasts with RNA generated from poliovirus type 3 (PV3/PV3) or poliovirus
type 1 and type 3 (PV1/PV3) cDNAs. The error bars indicate the standard deviation of three independent assays with significance determine by chi
square test (p=0.01).
doi:10.1371/journal.ppat.1004191.g001
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and subsequent isolation strategy is illustrated in Figure 1b. For
convenience, and because it refers to the parental genomes used in
the assay, we designate this as a CRE-REP recombination assay.
We initially investigated the ability to generate intra-serotypic
recombinants using parental genomes derived from poliovirus type 3
as we reasoned that – if sequence identity or protein-protein
compatibility influenced the efficiency with which viable recombi-
nants could be recovered – this would impose the minimum
constraints on the process. L929 murine fibroblasts were transfected
– individually or together – with RNA generated in vitro from
pT7Rep3-L and pT7/SL3. Cell-free supernatant was harvested 24–
48 hours post-transfection and the presence of infectious virus
detected by plaque assay in HeLa cells. Individually, neither parental
genome yielded virus capable of forming plaques on the HeLa
monolayers. In contrast, undiluted supernatant from co-transfected
L929 cells yielded ,1.16103 pfu/ml of virus (Figure 1cd), the
identity of which was confirmed by PCR analysis and subsequent
sequencing. L929 cells yielded no recombinants when the growth
media was supplemented with 4 mM guanidine hydrochloride, a
known inhibitor of poliovirus negative strand initiation [58].
We sequenced several biologically cloned intra-serotypic
recombinants (see below). However, the inevitable sequence
identity of the parental viral genomes confounded the identifica-
tion of recombination junctions in the majority of recovered
viruses. Therefore, having demonstrated the recovery of viable
progeny after co-transfection of a sub-genomic replicon and CRE
mutant we repeated the experiment replacing the poliovirus type
3-derived luciferase-encoding sub-genomic replicon with an
equivalent replicon derived from poliovirus type 1 (plasmid
pRLucWT; 21% divergent within the potential recombination
region shown in Figure 1). In this instance co-transfection of both
parental plasmids routinely generated 50–200 pfu/ml (mean of
115 pfu/ml from three independent replicates) from transfected
murine L929 cells following transfer of undiluted supernatant to
HeLa cell monolayers (Figure 1d). In repeated independent co-
transfections of mouse or hamster (L929 or BHK respectively; not
shown) monolayers, homologous (PV3/PV3) parental genomes
yielded ,10-fold more progeny than heterologous (PV1/PV3)
parental genomes (P,0.05 Mann Whitney U test; Figure 1d).
Inter-serotypic poliovirus recombinants were biologically cloned
by limit dilution and analysed further.
Sequence analysis of poliovirus recombinants
Fifteen intra-serotype recombinants were analysed after co-
transfection of L929 monolayers with RNA generated in vitro from
pT7Rep3-L and pT7/SL3. Recovered virus was reverse transcribed
using an oligo-dT primer and the region within which a
recombination event was targeted to occur was amplified using
oligonucleotides PV3-2995F and PV3-5191R (Supplementary Table
S1) and subsequently sequenced. The majority (n = 13) of the
recovered genomes were indistinguishable from the parental type 3
poliovirus genome. However, to our surprise two genomes included
a duplication, of either 27 nt. (PV33393/PV33367; see Materials and
Methods for nomenclature used to define recombinants and
recombination junctions) or 78 nt. (PV33390/PV33313) within the
region encoding the 2A protease (Figure 2a). We designated these
types of recombinants as imprecise reflecting the nature of the junction
between the donor (assumed to be the 39 partner encoding the viral
polymerase) and recipient parental genomes. Since further analysis
of such imprecise recombinants was limited by the sequence identity
of the parental viruses we went on to analyse the products from a
PV1/PV3 inter-serotypic co-transfection.
A total of 146 viable viruses were biologically cloned by limit dilution
of cell-free supernatant after three independent co-transfections of
L929 cells with equimolar ratios of RNA generated in vitro from
pRLucWT and pT7/SL3. Following reverse transcription, the
oligonucleotides PV3-2995F and PV1-5200R (Supplementary Table
S1) were used to amplify the intervening region. Initial analysis by gel
electrophoresis indicated that a significant proportion of the products
were larger that the expected size of 2205 nt. (data not shown). All
amplified products were therefore sequenced. Of these, 10 were
discarded as the sequence was ambiguous indicating they did not
contain a clonal virus population. The remaining 136 viruses all
consisted of recombinants in which the 59 component was derived from
the PV3 cDNA pT7/SL3 and the 39 component was derived from the
PV1 sub-genomic replicon, pRLucWT. These were stratified – on the
basis of the unique sequence that defined the junction – into 20 distinct
groups (illustrated schematically in Figure 2b; Figure S1). Of these,
three groups (#4E, #35C and #44B) contained a recombination
junction in which no additional sequences were present, located in
either the region encoding the C-terminus of 2Apro (#35C) or the 2C
protein (#35C and#44B; in the latter group the junction was defined
by the mutation engineered into the SL3 parental virus [56]). We
designate these as precise junctions i.e. in a sequence alignment of the two
parental genomes, the locations of the 39 nucleotide of the recipient
genome and the 59 nucleotide of the donor are adjacent. The
remaining 17 distinct recombination groups contained junctions in
which additional sequences of 3 to 321 nt. were present (i.e. imprecise
junctions). All imprecise junctions maintained the open reading frame.
In eight groups the 59 nucleotide of the donor was located within the
luciferase encoding region of the PV1-derived sub-genomic replicon.
These groups, together with groups#32A (in which the PV1 sequence
started within the linker between the reporter gene and the 2Apro-
coding region; Figure 2b and Figure S1) and #25A (see below),
contained an average 254 additional nucleotides and formed a distinct
cluster (Cluster 1) in which the imprecise junction spanned the region
encoding the VP1/2Apro cleavage site (Figure 2b). A second cluster
(Cluster 2), containing six groups with an average 118 additional
nucleotides had imprecise recombination junctions spanning the region
encoding the 2Apro/2B cleavage site. We included group#9C, which
contains a 3 nt. duplication within the region encoding the extreme
amino-terminus of the 2B protein, in Cluster 2. In six of the
recombination groups it was not possible to unambiguously define the
recombination junction due to local sequence identity between the
aligned parental genomes at the junction (#11A, #34D, #53A,
#67B,#E1 and#4E; Figure S1). Only one group (#25A) contained
virus-derived sequences that were not an effective duplication of
adjacent sequences at an imprecise junction. This group additionally
contained 16 nts. derived from the 59NCR (nts. 447–462) of a total of
243 nts. additional sequence present within the crossover region
(Figure S1). Since this region of the 59 NCR was identical in the
parental genomes it was not possible to determine which it had been
derived from.
Growth characteristics and serial passage of recombinant
viruses
Of the 136 heterotypic recombinants sequenced, the majority –
both in terms of individual sequences (95/136) or distinct groups
(17/20) – contained additional sequences within the recombina-
tion region (Figures 2b and S1). Since recombinant polioviruses
previously reported do not contain additional sequences we
reasoned that these imprecise recombinants might have a growth
disadvantage. We therefore investigated the growth characteristics
and stability of the virus genome upon serial passage of selected
recombinants.
A recombinant from group #51G (PV33874/PV12785, cluster 2;
Figure S1) was passaged a dozen times in HeLa cells. The plaque
phenotype and single step growth characteristics of the second (P2)
Recombination in Enteroviruses Is Biphasic Replicative Process
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and seventh (P7) passage were compared with the parental
poliovirus type 1 and type 3 (Figure 3ab). The initial small plaque
phenotype (P2) increased by P7 to one close to that of either
poliovirus types 1 or 3. In a single step growth analysis the P7 virus
was indistinguishable from poliovirus type 1 or type 3, whereas the
P2 virus had a lower yield at all time points tested, with a titre at
24 hours ,1 log10 reduced. This suggested that serial passage of
#51G resulted in changes that favoured the selection of viruses
with faster replication kinetics and a large plaque phenotype. RNA
therefore was purified at P2, P3, P7 and P12, reverse transcribed
and the region spanning the recombination junction amplified by
PCR using oligonucleotides PV3-2995F and GEN-4615R. In early
passages (P2, P3) a single product was amplified of ,1.7 kb but
was largely replaced by P7 (and totally by P12) with a PCR
product of a reduced size (Figure 3c). The P7 product was cloned
and eight resulting cDNAs selected at random were sequenced.
Four distinct junction sequences between poliovirus types 1 and
3 were identified (Figure 3d; #51G-a to –d in Figure S2). In each
case the product contained a precise junction in which there were
no additional duplicated sequences from either parental genome.
Figure 2. Recombination generates imprecise junctions with genome duplications. A) Imprecise recombinants recovered following co-
transfection of murine L929 cells with RNA generated in vitro from pT7Rep3-L (upper genome) and pT7/SL3 (lower genome). The junction sequence
of two imprecise recombinants, indicated with dashed lines, are shown. Upper and lower case characters are used to distinguish between those
derived from the CRE-defective genome (pT7/SL3) and sub-genomic replicon (pT7Rep3-L) respectively, with the extent of the sequence numbered
according to the reference genomes (see Materials and Methods). For each imprecise recombinant the number prefixed with a plus sign indicates the
additional nucleotides incorporated at the junction. B) Schematic diagram showing the location of recombinant junctions characterised following co-
transfection of murine L929 cells with CRE-defective type 3 poliovirus genome (pT7/SL3; dark shading) and poliovirus type 1 sub-genomic replicon
RNA (pRLucWT; light shading). The graduated shading in the upper genome indicates the region within which recombination must have occurred to
generate viable progeny virus. The expanded portion of the genomes (below) indicate the position of the junctions in the polymerase donor
(pRLucWT) and recipient (pT7/SL3) genomes. Solid lines indicate the groups of imprecise junctions – defined by sequence – which are grouped into
two clusters spanning the P1/P2 and 2A/2B boundaries. The thickened line in one of the cluster 1 imprecise recombinants indicates the genome
bearing additional sequence derived from the 59 NCR (#25A see Figure 3). Precise recombinants are indicated with vertical dotted lines within the 2A
and 2C coding regions.
doi:10.1371/journal.ppat.1004191.g002
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The four distinct junctions all mapped within the limits of overlap
in the original recombinant PV33874/PV12785 and to the region of
the genome encoding the C-terminus of 2Apro (Figure 3d). In each
case it was not possible to unambiguously identify the junction due
to identity of 2–4 nucleotides at the crossover region.
Three further recombinants, one more from cluster 2 (#E1;
PV33849/PV12830) and two from cluster 1 (#53A, PV33485/
PV12256 and #105B, PV33471/PV12287) were similarly analysed.
In each instance, serial passage (6 to 12 times) in HeLa cells
resulted in the internal deletion of sequences present within the
region duplicated in the imprecise junction, confirmed by
sequence analysis of 8 randomly selected cDNAs (Figure 3d). All
eight sequences recovered from recombinant #E1 were identical,
as were those from #53A, whereas recombinant #105B yielded
two distinct precise junctions (Figure S2). As before, in all cases the
exact recombination junction could not be defined due to the
conservation of 2–13 nucleotides at the junction (Figure S2). We
interpreted these results as indicating that the recombination
process in enteroviruses is biphasic – the initial generation of an
imprecise recombinant followed by the selection of precise
recombinants with enhanced fitness.
Construction and selection of an imprecise recombinant
The process by which initial recombinant genomes were
generated – cloning by limit dilution with minimal passage –
meant there was a possibility that they were not truly clonal but
instead may have contained undetectable levels of precise
recombinants. Potentially these subsequently out-competed the
imprecise recombinant, rather than being derived from it. To
exclude this possibility we constructed a complete cDNA for the
Figure 3. Serial passage of recombinants with imprecise junctions generate viruses with increased fitness bearing precise
junctions. A) Plaque phenotypes in HeLa cell monolayers of parental (PV1, PV3) and recombinant viruses (#51G) following two (P2) or seven (P7)
passages of the latter in HeLa cells. B) Single step growth analysis over 24 hours of parental viruses (PV1, solid line; PV3, dotted line) and #51G
imprecise recombinant virus before (dashed line) and after (mixed dotted and dashed line) seven serial passages is HeLa cells. Virus titre (in pfu/ml)
shown is the average of three independent assays. C) RT-PCR analysis of the junction region in recombinant#51G during serial passage in HeLa cells.
Viral RNA was reverse transcribed using an oligo-dT primer and cDNA amplified using primers PV3-2995F and GEN-4615R. The resulting products
were analysed by horizontal agarose gel electrophoresis after staining with ethidium bromide. D) Schematic diagram of precise recombinants derived
by serial passage of the imprecise recombinants indicated. Solid lines (#105B = blue, #53A = red, #51G = green, #E1 = black) indicate the
original imprecise recombinant with colour-matched dashed lines indicating the position of the resulting precise junctions.
doi:10.1371/journal.ppat.1004191.g003
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#105B recombinant (PV33471/PV12287; see Materials and Meth-
ods) and transfected L929 cells with RNA transcribed in vitro.
Supernatant media from transfected L929 cells contained
,86104 pfu/ml of virus as quantified by plaque assay in HeLa
cells. This virus population was subjected to further serial passage
and analysed by PCR as before. After four passages a product
indistinguishable in size from that of the parental poliovirus
genome remained visible together with one or more additional
smaller PCR products, intermediate in size between the starting
material and the parental poliovirus genome (data not shown).
After three further passages the amplified PCR product was cloned
and six clones were sequenced. Of these, four (#105B-3; Figure
S2) exhibited an identical imprecise junction, PV33381/PV12389,
between the PV3- and PV1 replicon-derived sequences. This
differed from that present in the input genome (#105B, PV33471/
PV12287; Figure S1) but retained 57 nt. derived from the region
encoding the C-terminus of the luciferase reporter gene. The two
remaining sequences exhibited different precise junctions (#105B-
1, #105B-2; Figure S2). One of these (#105B-1, PV33378/
PV12443; Figure S2), exhibited an identical precise recombination
junction to that selected previously by serial passage of recombi-
nant viruses cloned by limit dilution from a co-transfection of PV3
and pRLucWT (#105B-a; Figure S2). These results strongly
support our contention that the imprecise recombinants isolated
from L929 cells using limited passage and serial dilution are the
likely progenitors of the precise recombinants subsequently
selected by serial passage in HeLa cells. Furthermore, the
identification of an imprecise recombinant with a duplicate
sequence reduced in length from the input (249 nt. in #105B cf.
57 nt. in #105B-3, see Figure S2) suggests that the generation of
precise recombinants may progress via intermediate imprecise
recombinants.
Are recombinants generated by a replicative or non-
replicative process?
The CRE-REP assay we have developed (Figure 1) was based
on the assumption that recombination occurs via a copy-choice
mechanism during negative strand synthesis. However, formally
the mechanism could have been replication-independent, as has
been reported for a number of positive strand RNA viruses
including enteroviruses, BVDV and HCV [50,52,53]. To clarify
this we investigated the consequences of modifying the polymerase
error rate, reasoning that a replicative process might be influenced
by the characteristics of the polymerase. We therefore investigated
the frequency of recombinant generation in the presence of
ribavirin, an antiviral which induces a well-characterised increase
in the poliovirus polymerase errors rate [59]. We also determined
the influence of a G64S substitution in the polymerase, a mutation
that confers resistance to ribavirin [60] as a consequence of
increased polymerase fidelity [61]. We additionally investigated
the influence of the drug nocodazole on recombination as previous
studies have shown it inhibits the formation of mixed replication
complexes which we presumed are required for replicative
recombination [62]. In each instance we also investigated the
influence of these various treatments or modifications on the
generation of recombinants in a non-replicative assay.
We initially compared the yield of intra-serotype recombinants
in the CRE-REP assay we developed (Figure 1) with the yield from
truncated – and therefore non-replicating – pT7/SL3D and
DpRLucWT templates (see Materials and Methods for details).
Using equimolar amounts of each RNA, and the same total
amount of RNA for the CRE-REP or non-replicative transfection of
L929 cells, progeny virus was quantified in the supernatant. Under
these conditions, the yield of recombinants in the non-replicative
assay was only 3.8% of the yield produced in the CRE-REP assay
(Figure 4a). Ribavirin concentrations greater than 400 mM elimi-
nated the generation of recombinant progeny following co-
transfection of rodent cells with RNA derived from pT7/SL3 and
pRLucWT, a result in agreement with previous data on the
inhibitory concentration of ribavirin [59]. In contrast, concentra-
tions of ribavirin of 200 mM and 100 mM increased the yield of
progeny virus (over that produced in the absence of ribavirin)
significantly, by ,2 fold and ,3 fold respectively (Figure 4b).
However, 100 mM ribavirin did not influence the yield of progeny
from a non-replicative assay (Figure 4c) using the truncated pT7/
SL3D and DpRLucWT versions of the cDNA templates. Ribavirin
concentrations over the range tested also had no influence on
transfection efficiency of L929 cells (Figure S3).
In contrast to the enhancing effect of ribavirin use of donor and
recipient genomes bearing a 3Dpol G64S high-fidelity substitution
markedly reduced the yield of recombinants in the CRE-REP
assay, by ,20-fold (Figure 4d), despite the mutation having no
discernible influence on poliovirus replication ([60]; Figure S4). In
a parallel non-replicative recombination assay, using the truncated
sub genomic replicon template bearing the same G64S polymerase
mutation, there was no significant influence on the yield of
progeny recombinants (Figure 4e).
Nocodazole treatment (5 mM) of transiently chilled cells
prevents repolymerization of microtubules and the consequent
coalescence of replication complexes, yet does not inhibit virus
replication or yield ([62,63]; Figure S5). In the CRE-REP assay,
prior treatment of cells with nocodazole reduced the intra-
serotypic yield of recombinants by ,70% (Figure 4f). In contrast,
similarly treated L929 cells transfected with RNA from the pT7/
SL3D and DpRLucWT non-replicative versions of the same
templates, generated similar levels of recombinant progeny to
untreated cells (Figure 4g). Taken together, the influence of the
polymerase characteristics and the requirement for replication
complex mixing strongly suggests that the generation of recom-
binants in the CRE-REP assay involves a replicative process.
Analysis of imprecise and precise recombination
junctions
Previous studies have implicated local RNA secondary struc-
ture, sequence composition or template identity as influencing
recombination [64–66]. To investigate this further the amount of
RNA structure on the positive and negative sense genome was
determined by calculating the mean folding energy difference
(MFED) between the native sequence and sequence order
randomized controls [67] over a sliding 250 nt window spanning
the region within which recombination could occur (Figure 5a).
MFED values ranged between +5% and 215%, with positive
values indicating the presence of sequence order-dependent
structure. The average MFED value for sense and antisense
strands was 1.58% and 21.56% respectively for the type 1 sub-
genomic replicon (the donor genome) and 21.95% and 23.89%
respectively for the poliovirus type 3 recipient genome. Neither the
precise or imprecise junctions mapped to the regions with
maximum or minimum predicted RNA structure (positive and
negative values respectively in Figure 5a) between the luciferase
coding region and defective CRE. To exclude the possibility that
the use of a sliding window during MFED calculations may have
obscured limited localized secondary structure, we also determined
the MFED value for the 100 nt window spanning each mapped
junction in the donor and recipient genomes by comparison of the
native sequence to 999 sequence-order randomized controls, using
a scrambling algorithm (NDR) that maintained key features, such
as dinucleotide composition, of the sequence. Both precise and
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imprecise junctions exhibited positive MFED (i.e. structured)
values in the positive strand of donor sequences (Figure 5b; dark
bars), though the MFED values were near an arbitrary 4% cutoff
we have previously considered marks the lower limit of reliably
predicted RNA structure [68]. In contrast, the negative strand
(Figure 5b; pale bars) of both precise and imprecise junctions was
largely unstructured, and this was particularly marked in the
negative strand of precise recipient sequences.
Sequence identity within the potential recombination region
ranged from ,27% (luciferase and VP1) to almost 98% in the
sequence that forms the CRE, and averaged 79.9% within P2-
coding region (Figure 6a), distributed as short regions of identity
between 2 and 21 nt. in length interspersed with variant
nucleotides. There was no correlation between the length of
sequence identity and the frequency or distribution of the precise
recombination junctions. For example, in the aligned sequences
there were 99 distinct conserved dinucleotides (almost all being the
first two nucleotides of aligned codons) but only 10 positions with
identity of 12 nt. or greater. Of the precise junctions characterised,
50% occurred at positions with identical dinucleotides, with only
10% occurring at regions of identity of more than 12 nt. (Figure 5c,
Figure S1). Finally, detailed analysis of the 15 nt. sequences
flanking every junction obtained, both precise and imprecise,
failed to detect any significant biases whether quantified as
individual nucleotides (A,C,G,U), grouped as (A+U) or (C+G) or
as purine/pyrimidines (data not shown).
Discussion
The rapid evolution of single-stranded positive-sense RNA
viruses can be attributed to their error-prone RNA dependent
RNA polymerases (RdRp) and the ability of their modular
genomes to undergo recombination. Coupled with their generally
short replication cycles and high yields this allows rapid adaptation
to altered environmental conditions and the acquisition of novel
tissue or host tropisms [69,70]. In recipients of the live attenuated
poliovirus vaccine recombinants are excreted within 7 days
[18,19,71]. Furthermore, recombination between Sabin vaccine
strains and co-circulating – and co-infecting - enteroviruses can
generate novel neurovirulent chimeras capable of spreading within
a community with low vaccine coverage [27,72,73]. Further
studies have demonstrated that recombinant forms of particular
serotypes of human enteroviruses wax and wane in their relative
geographical dominance with characteristic half lives [23–25].
Despite recombination being a well defined phenomena in
picornaviruses of humans and animals [13,74], as well as other
important positive-strand RNA virus pathogens [44,75–77], the
underlying mechanism(s) by which recombinants arise are
relatively poorly understood. Studies have suggested that the
copy-choice template-switching model originally proposed [47]
was additionally influenced by sequence identity between parental
genomes, in particular short direct sequence repeats [65,78] or by
the RNA secondary structure of donor or recipient molecules
[49,66,79,80].
These analyses have generally assumed that the selected
recombinant genome contains a junction that reflects the point
at which the polymerase switched from donor to recipient
template. To test this we reasoned it would be necessary to isolate
recombinants as soon as possible after they had arisen, before
additional selection by serial passage and inevitable competition
amongst the viral population. To achieve this we investigated the
recombination between a poliovirus sub-genomic replicon [81,82]
and a genome defective in positive-strand RNA synthesis due to
disruption of the CRE [55,57,83,84]. By transfecting RNA into
rodent cells, which lack the receptor for poliovirus, we prevented
reinfection and so could analyse early products of recombination.
To ensure we were analyzing replication-competent genomes we
biologically cloned progeny virus by limit dilution in HeLa cells
before genome analysis.
Having determined that neither parental genome generated
viable revertants (Figure 1c) we quantified progeny virus generated
by intra- (poliovirus type 3) and inter-serotypic (poliovirus type 1
and type 3) recombination. Using standardized conditions intra-
serotypic recombinants arose approximately ten-fold more fre-
quently that inter-serotypic recombinants (Figure 1d). Based upon
the known recovery (pfu/mg) of type 1 and type 3 poliovirus in
L929 cells following RNA transfection (data not shown) it was
Figure 4. Comparison of the CRE-REP with non-replicative recombination assays and the influence of the viral polymerase on
recombination. A) Recombinant virus yield in the CRE-REP and non-replicative recombination assays. Equimolar amounts of RNA generated in vitro
from pT7/SL3 and pRLucWT or pT7/SL3D and DpRLucWT respectively – 0.5 mg total – were transfected into L929 cell monolayers. Viable progeny
virus was harvested at 48 (CRE-REP) or 60 (non-replicative) hours post-transfection and quantified by plaque assay on HeLa cell monolayers. Virus
yield is normalized to the yield in the CRE-REP assay, with error bars indicating standard deviation of three independent assays. B) Recombinant virus
yield in the CRE-REP assay upon co-transfection of L929 cells in the presence of different concentrations of ribavirin. L929 cell monolayers were pre-
treated with ribavirin at the concentrations indicated, transfected with RNA generated in vitro from pT7/SL3 and pRLucWT. After 48 hours in the
presence of ribavirin, virus in the supernatant was quantified by plaque assay on HeLa cells. Results are presented (average of three independent
assays with error bars indicating standard deviation) as the percentage with reference to transfected untreated monolayers, with statistical
significance (** = p,0.001) determined by student t tests. C) The influence of 100 mM ribavirin on the yield of viable progeny virus from a non-
replicative recombination assay. L929 cell monolayers pre-treated with 100 mM ribavirin were transfected with RNA generated in vitro from pT7/SL3D
and DpRLucWT. After 60 hours, viable recombinant virus in the supernatant was quantified by plaque assay on HeLa cells. Results are normalized to
the yield of progeny recombinant virus from the same truncated templates in the absence of ribavirin, with error bars indicating the standard
deviation in three independent assays. D) Comparison of recombinant virus yield in the CRE-REP assay upon co-transfection of L929 cells with RNA
generated in vitro from pT7/SL3 and RNA from either an unmodified (wildtype; WT) poliovirus type 1 sub-genomic replicon (pRLucWT) or a derivative
bearing a high-fidelity G64S substitution in the viral 3D polymerase (pRLucWTG64S). Results are presented (average of three independent assays with
error bars indicating standard deviation) as the percentage normalized to pRLucWT, with statistical significance (** = p,0.001) determined by student
t tests. E) The influence of a G64S high fidelity polymerase mutation on the yield of viable progeny in a non-replicative recombination assay. As
above, L929 cell monolayers were transfected with RNA generated in vitro from unmodified or G64S-bearing DpRLucWT templates and RNA from
pT7/SL3D. Results presented are the percentage yield normalized to the unmodified truncated templates, with error bars indicating the standard
deviation of three independent assays. F) The influence of nocodazole on recombinant yield in the CRE-REP assay. As before, RNA generated in vitro
from pT7/SL3 and pRLucWT was transfected into L929 cells previously chilled and treated with 5 mM nocodazole (+; see Materials and Methods for
details). Results are normalized to the yield from the same templates in the presence of DMSO carrier alone (-), with error bars indicating the standard
deviation of three independent assays (** indicates p,0.005, student t tests). G) The influence of nocodazole on non-replicative recombination. RNA
was generated in vitro from pT7/SL3D and DpRLucWT and transfected, as above, into nocodazole (+) or DMSO carrier-treated (–) L929 cell
monolayers. The results show the percentage normalized yield to controls, with error bars indicating the standard deviation of three independent
assays.
doi:10.1371/journal.ppat.1004191.g004
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Figure 5. The analysis of recombination junctions. A) Influence of sequence identity and local RNA structure on recombination junctions. The
central panel shows the donor (dark shading) and recipient (light shading) partial genomes with protein coding regions indicated flanking a line graph of
sequence identity (%) between the non-structural regions of poliovirus type 1 and type 3. Above and below are shown graphs of the mean folding
energy differences (MFED; indicated as the percentage difference from 999 sequence-order randomized controls) – a measure of sequence-independent
localized RNA structure – over a 250 nt. sliding window (in 30 nt. increments) in the sense and antisense genomes, indicated in solid and dotted lines
respectively. The locations of precise and imprecise recombination junctions are indicated in the top and bottom panels by right angle arrows. B) The
mean folding energy difference (MFED; percentage difference from 999 sequence order randomized controls) of 100 nt. regions spanning precise and
imprecise junctions in donor (sub-genomic replicon) and recipient (CRE-mutant) sequences. Dark and pale shaded bars indicate the MFED of the
positive- or negative-sense strand respectively. D and R indicate the donor and recipient sequences respectively. The error bar indicates the standard
error. C) Precise junctions do not occur in regions of maximum sequence identity between recombination partners. Individual counts of short lengths of
sequence identity between pRLucWT and pT7/SL3 (pale shading; left axis) within the 1058 nt. separating the start of the P2 coding region and the CRE
and (dark shading; right axis) counts of precise recombinants exhibiting short regions of identity at the junction (see Figure 3).
doi:10.1371/journal.ppat.1004191.g005
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estimated that intra-serotypic recombinants would represent ,1-
10% of the progeny, broadly in line with figures previously
reported [47,85,86]. However, as this would be influenced by
absolute levels of replication of the unmodified genomes, by the
co-transfection efficiency and by the amount of replication post-
recombination, this was not further investigated.
The majority of intratypic poliovirus recombinants were
indistinguishable from a parental poliovirus type 3 genome.
However, intriguingly, two of the sequences contained genome
duplications, of 27 or 78 nt. (Figure 2a). This prompted us to
analyse an extensive panel of intertypic poliovirus type 1/type 3
recombinants in which the 21% sequence divergence between the
selection markers (the luciferase coding region and the mutated
CRE) facilitated identification of recombination junctions. Of 136
genomes in which the sequence could be unambiguously
identified, 95 (70%) contained additional sequences, forming 17/
20 (85%) distinct sequence junctions analysed. We termed these
imprecise junctions to distinguish them from genomes bearing no
additional sequences (precise junctions). We prefer the use of the
terms precise or imprecise – rather than homologous or non-
homologous – as they define the characteristics of the recombi-
nation junction with regard to the parental virus genome, rather
than the mechanism by which recombination occurred.
Recombinant virus progeny were obtained upon co-transfection
of rodent (mouse, hamster) and human (HeLa) cell lines, with no
strong evidence for cell specificity; we regularly observed a ,2.5
fold higher yield in hamster cells compared with mouse cells but
consider this reflects differences in transfection efficiency and
genome replication (data not shown). Both precise and imprecise
recombinants were recovered in all the cell types tested. In rodent
cells we observed different ratios of precise to imprecise
recombinants in repeated parallel co-transfections. We believe
this represents the stochastic temporal nature of an individual
recombination event and subsequent replication; recombinants
arising soon after transfection would be expected to yield genomes
that would undergo multiple additional rounds of replication, with
the possibility of secondary events (see below) therefore being more
likely to yield precise recombinant progeny with enhanced fitness.
It should be noted that the CRE-REP assay we describe here
involves analysis of progeny 24-48 hours post transfection. During
this period, selection for genomes with enhanced replication likely
occurs, so the genomes analysed are an indicative, rather than
exhaustive, representation of early recombination products. Based
upon our demonstration of enhanced replication kinetics after
passage (Figure 3ab) we speculate that precise recombinants arise
following rapid selection from an initial imprecise recombinant,
and that they quickly outcompete the less fit recombinants to
prevail in the analysed population. We also note that precise
recombinants were usually represented multiple times during the
group analysis (Figure S1), suggesting that once they had appeared
in the population their enhanced replication meant that they
rapidly became the dominant virus present. This interpretation
could be addressed by next generation sequencing analysis of the
viral RNA population of co-transfected (or infected) cells in future
studies.
All recombinants were harvested from transfected cell superna-
tant and isolated by limit dilution in HeLa cells. This would have
imposed a minimal viability criteria on the genome of being
encapsidated and capable of being both translated and replicated.
By definition, the imprecise recombinants obtained contained
partial duplications of parts of the genome. Although the
packaging limit of poliovirus is not known, previously constructed
dicistronic viruses have contained at least an additional 573 nt.
[87] and the genome of foot and mouth disease virus, which
possesses a similarly sized particle, is 8.2 kb. It is therefore unlikely
that the largest imprecise genome obtained (#67B; 321 nt.; Figure
S1) represents any sort of packaging limit, but rather reflects the
selection assay used or the mechanism of recombinant generation.
Furthermore, since recombinant populations are usually mixtures
(generated in vivo in the presence of fully viable parental viruses),
both the size and range of the additional sequences may represent
genomes which retain sufficient replicative fitness to compete in a
mixed infection. How do imprecise recombinants, possibly of
lower fitness, compete at all in a natural infection? We think this
reflects the stochastic nature of the infection and transmission of
enteroviruses. A replication-competent recombinant, even of only
limited fitness, shed from the initial dually infected cell would
presumably either infect another cell in the same host, or be shed
into the environment. Although locally the multiplicity of infection
in the original host may be high (and the recombinant poorly, if at
all, competitive with parental viruses), transmission to distant sites
in the same host or another host may result in a founder effect, in
Figure 6. A biphasic model for replicative recombination in
enteroviruses. Template switching during negative-strand synthesis
(indicated by a dashed arrow) results in the generation of a chimeric
intermediate in which parts of the genome are effectively duplicated.
Numbering and background shading indicates the source of the
original sequences from the parental genomes and shows the
duplicated sequences. During subsequent rounds of replication these
undergo resolution by internal deletion (or potentially further
recombination) events to generate a range of genome-length progeny
either directly or via intermediates (indicated by grey background
shading). A single initial recombinant can give rise to a range of
different genome-length final products. The recombination and
resolution events may occur in the initial dually infected cell (in which
case negating the requirement for the original chimeric genome to be
encapsidated) but – as in the assay presented in Figure 1 – can also
occur in a different cell following re-infection.
doi:10.1371/journal.ppat.1004191.g006
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which the recombinant – or subsequent resolved derivatives of it –
can proliferate in the absence of parental genomes of potentially
greater fitness.
A striking feature of the imprecise recombinants recovered was
their clustering in regions encoding the amino and carboxyl
termini of 2Apro (Figures 2b, 3d). The consequences of this
clustering was that the majority (94/95 individual sequences in
16/17 groups) of imprecise recombinants retained the ability to
encode non-chimeric versions of the 2Apro and 2B proteins; the
sole exception being #9C in which the additional 3 nt. at the
junction occurred within the first few conserved codons of the 2B
coding region (Figure S1). The junctions generated in Cluster 1
encoded both 2Apro and 2B from the sub-genomic replicon
recombination partner (the polymerase donor) and those in
Cluster 2 encoded 2B from the donor and 2Apro from the
recipient poliovirus type 3 genome. We propose that this clustering
is a consequence of the overriding requirement for functional
2Apro and 2B proteins in the initial recombinant and that this is
rarely, if ever, achieved in a single step. Since imprecise
recombinants are viable and can serve as the source for subsequent
precise recombinants (Figure 3; Figure S2), it seems logical that
this mechanism increases the chance by as much as two orders of
magnitude (cf. generation of a precise recombinant with an
imprecise recombinant containing 3–321 nt. of additional se-
quence) of generating the latter. It should be noted that the
polyprotein encoded by imprecise recombinants would include an
additional 2Apro or 3Cpro cleavage site (Figure 2B). Since these
provide an authentic context for proteolytic processing we
presume this contributes to the viability of such imprecise
recombinants. The 16 nt. insert derived from the 59 NCR present
in #25A must have arisen by two relocations of the viral
polymerase with regard to the template. Since this sequence is
identical in the parental genomes it is not clear which it was
derived from, though at least one of the polymerase template
reassociations must have been in cis. It is unclear why imprecise
recombinants spanning the 2B/2C junction were not recovered in
our analysis, whereas precise recombinants in 2C (#4E and
#44B; Figure 2b, Figure S1) did occur. One possibility is that the
assay used (Figure 1) requires that the hybrid genome is capable of
establishing a productive infection in HeLa cells and that
imprecise recombinants across 2B/2C are unable to do this due
to deficiencies in homodimerisation, membrane permeabilization
or formation of the replication complex [88–91]. Alternatively, this
may indicate that the higher order structure of one or both of these
proteins involves a ‘head to tail’ interaction in which the interface
is between the amino terminus of one subunit and the carboxyl
terminus of the other. Related to this point, it is also interesting to
note that there is a reported asymmetry in reciprocal recombinants
in the P2 region of poliovirus and related species C coxsackie A
viruses which may reflect important protein-protein interactions
required for genome replication and particle assembly [45].
The yield of intra-serotype recombinants was ,10-fold higher
than inter-serotype recombinants (Figure 1d) and, although only a
limited number were sampled, a greater proportion of the former
were precise (87% 13/15 cf. 30% 41/136 of inter-serotype
recombinants). Further studies will be needed to determine
whether the increased proportion of precise junctions is due to
the sequence identity of the parental genomes, reflecting its role in
the underlying recombination mechanism. This may also influence
the yield of recombinants. However, protein-protein compatibility
is also likely to influence both the yield and type of viable
recombinants generated. Identical parental genomes inevitably
encode proteins that have co-evolved and have presumably
achieved optimal compatibility. This may enhance the replication
and subsequent resolution (see below) of imprecise intra-serotype
recombinants. In contrast, even the limited sequence divergence at
the amino acid level between the parental serotypes (4–9%
divergence at the amino acid level between poliovirus type 1 and 3
proteins 2Apro, 2B and 2C), might compromise the fitness of inter-
serotype recombinants. Future analysis should therefore include
looking for adaptive changes potentially some distance from the
recombination site.
We propose that the recombination process of enteroviruses is
biphasic (Figure 6), involving the generation of an initial imprecise
recombinant which – through a process we term resolution – yields
precise, genome-length, recombinants. The resolution process may
be direct, generating precise recombinants in a single step, or
indirect in which imprecise recombinants with shorter genome
duplications are generated. For example, the synthesised #105B
recombinant cDNA generated both precise and imprecise
recombinants upon serial passage (Figure S2). We predict that
resolution is an iterative process in which genomes with
incrementally increased fitness are selected from the pool of
molecules generated during replication. Whether resolution
involves intra- or intermolecular polymerase transfer remains to
be determined. In practice the resolution event may occur in the
same dually infected cell in which the initial recombinant was
generated. We think that this is the likely explanation for the
generation of precise recombinants in co-transfected L929 murine
cells (Figure 2). A biphasic recombination process is likely to have a
bearing upon the recombination junctions generated. For exam-
ple, the processes involved in the generation of imprecise and
precise junctions may be influenced – if at all – by different
contextual and sequence-dependent attributes. Prompted by the
observation that the majority of precise recombinants occur at
positions with limited sequence identity between templates
(underlined in Figures S1 and S2) we investigated the role of
primary sequence and RNA secondary structure. Other than an
apparent absence of structure in the negative strand of recipient
precise junctions (Figure 6b), which mechanistically seems unlikely
to contribute to the polymerase strand-transfer reaction, we found
no compelling evidence for a role for either primary sequence or
sequence order-dependent RNA structure in influencing the
recombination junctions observed. In contrast, Runckel and
colleagues have recently reported an elegant next generation
sequencing study of precise recombinants of poliovirus partners
tagged with synonymous mutations [64] in which sequence
composition and RNA structure correlated with, in a predictable
and modifiable manner, recombination hotspots. The application
of this type of approach to the imprecise junctions that
predominate in early recombinant populations is likely to allow
the separation of sequence/structural influences on the recombi-
nation process per se and the subsequent resolution process. The
independent isolation of the same precise recombinant by serial
passage of #105B virus recovered from co-transfection and from
an engineered cDNA (#105B-a and #105B-1; Figure S2) suggests
there may to be sequence-dependent influences on the sites of
recombination during the process of resolution. Alternatively, this
particular recombinant may have a subtle fitness advantage over
others generated, thereby prevailing upon serial passage. Further
studies on the relative fitness of precise recombinants, for example
by competition studies between known levels of two or more input
viruses [92], may help elucidate this.
As a prelude to investigating the influence of the polymerase on
the generation of recombinants we compared the relative yield of
viable recombinants in the CRE-REP assay and a non-replicative
assay [50,51] primed with the same amounts of truncated variants
of the same template RNA (Figure 4a). Under these conditions an
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intratypic CRE-REP assay generated ,25 fold more recombi-
nants. We went on to conduct three related studies that indicate
that the generation of recombinants in the CRE-REP assay is a
replicative process. By increasing (ribavirin) or decreasing (G64S)
the error rate of the viral polymerase we respectively enhanced or
suppressed the recovery of recombinants (Figure 4bd) in the CRE-
REP assay. In contrast, neither ribavirin nor the G64S polymerase
mutation influenced the yield of recombinants using a non-
replicative assay consisting of truncated RNA templates
(Figure 4ce). Further support for the replicative generation of
recombinants in the CRE-REP assay was provided by the
demonstration that nocodazole reduced the yield of recombinants
by ,70%, but had no effect on either genome replication ([62]
and Figure S5) or on the yield of recombinants from the non-
replicative assay (Figure 4fg).
The three-fold enhancement of poliovirus recombinant recov-
ery in the presence of ribavirin may have implications for the
therapeutic use of this antiviral drug. However, we acknowledge
that in hepatitis C patients – in which ribavirin is widely used
therapeutically – recombination is considered a relatively rare
event [93,94]. A mechanistic exploration of the enhanced
recombination observed in the presence of ribavirin clearly
deserves further analysis. In preliminary studies we have observed
that 5-fluorouracil also enhances the yield of recombinants in the
CRE-REP assay (data not shown). It is likely that extension of
these mutagenic inhibitor studies will provide further insight into
the precise mechanism of template disengagement and re-
engagement by the viral polymerase. Indeed, previous studies
have already proposed that mismatches induced by mutagens
enhance the dissociation of the template and the polymerase
[48,95]. However, it is interesting to note that in a limited range of
imprecise recombinants generated in the presence of ribavirin,
nucleotide substitutions were not observed at the recombination
junctions sequenced (Woodman and Evans, in preparation).
Since the templates used in the non-replicative assay were
identical (other than being either 59 or 39 truncated) to those used
in the CRE-REP assay, recombination must have had to occur
between the same genetic markers – the luciferase reporter gene
and the defective CRE (Figure 1) – to generate viable progeny. It is
therefore interesting to note that non-replicative recombination
generated only ,4% of the progeny of that produced in the
equivalent CRE-REP assay when transfecting equimolar amounts
of in vitro synthesized RNA into L929 cells (Figure 6a). This striking
difference in yield is further support that the CRE-REP assay is
likely mechanistically different from a non-replicative recombina-
tion event. Further support for this interpretation includes the lack
of inhibition of non-replicative recombination by nocodazole – this
implies this process occurs outside the confines of the replication
complex, or at least does not require co-occupied replication
complexes to occur. Finally, although non-replicative recombina-
tion, presumably involving cellular RNA exonucleases and ligases,
is well documented in a number of picornaviruses, flaviviruses and
alphaviruses [51–53,96] – and may generate the types of junctions
we define as imprecise [53] – the relative importance in vivo of
replicative and non-replicative mechanisms of recombinant
generation remain to be determined.
The CRE-REP assay we describe may also provide an approach
to study the restrictions on intra- and interspecific recombination
in enteroviruses, the former being far more frequent than the
latter. In preliminary studies we have recovered recombinants
between species B enteroviruses (echovirus 7; data not shown),
suggesting that the mechanism proposed from our studies using
poliovirus is likely generic to other enteroviruses, and presumably
to other picornaviruses which also exhibit recombination [97].
However, in repeated attempts we have been unable to recover
interspecies recombinants between reciprocal transfections of
species C and species B enteroviruses (poliovirus type 1 and either
echovirus types 6 or 7 respectively; data not shown). Further
studies may elucidate whether this is due to direct genomic
incompatibility, i.e. any recombinant genomes generated are non-
viable, perhaps because they are unable to replicate or undergo
proteolytic processing, or due to the absence of protein-protein
interactions necessary for encapsidation [46]. Alternatively the
rarity of interspecies recombination may reflect a lack of
opportunity, perhaps due to occupancy of distinct replication
complexes, sub-cellular or cellular compartmentalization.
The suggestion that an imprecise replicative recombination
process results in partial duplication of the virus genome also has
intriguing implications for our wider understanding of the
evolution of positive strand RNA viruses. There are several
variously well characterised evolutionary duplication events that
have shaped extant picornavirus genomes. These include the
capsid proteins (VP1-3) which share a common ‘jelly roll’ structure
[98], the three contiguous VPg proteins of foot and mouth disease
virus [99] and even the non-contiguous 2A and 3C proteases
[100]. In addition, other positive strand RNA viruses exhibit
genome duplications [101] such as the multiple VPg proteins of
some dicistroviruses [102] or the functionally distinct adjacent
leader proteinases of the Closteroviridae [103]. The type of imprecise
recombination event we describe, potentially coupled with partial
resolution, could account for this ‘evolution by duplication’.
Likewise, duplication and subsequent resolution events could
explain the permutation of the polymerase palm domain reported
in some Alphavirus-like insect tetraviruses [104]. Other than the
ancestral evolution of the capsid proteins the majority of these
involve duplication of relatively short sequences – this is presumed
to reflect intrinsic constraints on genome length [101], but may
also reflect the mechanism by which they are generated.
An improved insight into evolution of RNA viruses, including
acquisition of extensive regions of the genome by the process of
recombination, will improve our understanding of the basic
biology of this important group of viruses and help us identify how
the process can be controlled, avoided or exploited.
Materials and Methods
Virus and cell culture
HeLa, L929 murine fibroblasts and baby hamster kidney (BSR-
T7) cells were grown as monolayers in Dulbecco’s Modified Eagle
Medium (DMEM) or Glasgow Minimum Essential Medium
(GMEM supplemented with G418 antibiotic). Media was supple-
mented with 100 U/ml penicillin, 100 mg/ml streptomycin,
2 mM L-glutamine and 10% Heat Inactivated (HI)-FBS. All cells
were passaged in the presence of trypsin-EDTA. Where stated,
ribavirin (Sigma) or guanidine hydrochloride (Sigma) were added
to growth media at the concentrations indicated. Nocodazole was
used where required by treating pre-chilled cells (10 minutes at
0uC) with a final concentration of 5 mM in DMSO (essentially as
described previously; [62]) for two hours prior to transfection.
Poliovirus type 1 (Mahoney) and type 3 (Leon) were recovered
following transfection of RNA generated in vitro (see below) from
full length cDNA. Virus was quantified by plaque assay as
described previously [105]. Growth kinetics of viruses were
determined following synchronous infection of HeLa cells at a
multiplicity of infection (moi) of 10 pfu/cell. Unabsorbed virus was
removed by washing with sterile PBS and plates incubated in fresh
media at 37uC in an atmosphere containing 5% CO2. Virus in the
supernatant was quantified at various time points post infection by
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plaque assay. Virus competition assays were conducted by co-
infection of HeLa cells with an moi of 10 pfu/cell of each virus,
removing unabsorbed virus by washing in PBS and harvest of virus
from the fresh supernatant at either 24 hours post infection (p.i.) or
when cells displayed at least 50% cytopathic effect (cpe). When
serially passaging virus, harvested supernatant was diluted 1:4 with
fresh media. Recombinant viruses were biologically cloned by limit
(doubling) dilution in 96-well plates seeded with 16105 HeLa
cells/well. Plates were inoculated and incubated at 37uC/5% CO2
for four days after which time virus-containing supernatant was
removed (and stored) and the remaining cell monolayer stained
with crystal violet. Virus supernatant from the highest dilution
causing complete cpe was retained for further analysis.
Plasmids, in vitro transcription and cell transfection
pT7Rep3-L is a poliovirus type 3 (Leon) sub-genomic replicon
bearing a luciferase reporter gene inserted in-frame in place of the
P1 capsid coding region of the genome. pRLucWT is a pBR-based
plasmid containing a cDNA for a poliovirus type 1 sub-genomic
replicon in which the capsid coding region is replaced, in frame,
with a luciferase reporter gene, as previously described [106].
pT7/SL3 has also been described previously [56] and consists of a
full-length poliovirus type 3 (Leon) cDNA bearing 8 synonymous
substitutions in the cis-acting replication element (CRE) within the
2C-coding region. A variant of pRLucWT containing a Gly to Ser
substitution at residue 64 (hence designated pRLucWTG64S) of the
RNA dependent RNA polymerase was generously provided by
Craig Cameron and Jamie Arnold. The same mutation was built
into the pT7/SL3 cDNA using standard methods. Plasmids pT7/
SL3 and pRLucWT were linearised with Sal I and Apa I
respectively and transcribed in vitro using T7 RNA Polymerase
(Fermentas) following the manufacturer’s protocol. Residual DNA
template was removed by addition of 2 U DNase Turbo (Ambion)
and the RNA transcripts were purified using RNeasy Mini Kit
(Qiagen) before spectrophotometric quantification. Unless other-
wise stated, 0.5 mg or 1 mg (total) of equimolar amounts of both
template RNAs was prepared with Lipofectamine 2000 (Invitro-
gen; used according to the manufacturers instructions) and
transfected into confluent monolayers in 12 or 6 well dishes
respectively.
A full length cDNA of the recombinant virus genome
designated #105B was constructed using standard molecular
biology techniques from the parental pRLucWT and pT7/SL3
cDNAs together with the central region of the genome which was
RT-PCR amplified from #105B virus. The compete cDNA
sequence was validated before further analysis.
Truncated cDNA templates were generated from pT7Rep3-L,
pRLucWT and pT7/SL3 for use in non-replicative recombina-
tion assays, essentially as previously described [50]. Briefly,
pT7Rep3-L and pRLucWT were digested with Pml I and Pac I
and religated, effectively removing the entire IRES and the
majority of the luciferase coding region. Similarly, pT7/SL3 was
digested with Xho I and Sal I and religated, removing the
polymerase coding region. Truncated templates are indicated
with a prefix or suffix D where appropriate e.g. pT7/SL3D.
Where required, template cDNAs were modified by inclusion of a
G64S substitution in the viral polymerase using standard
methods. Non-replicative recombination assays were always
conducted in parallel with the CRE-REP assay (see above) and
used equimolar ratios of RNA (total 0.5 mg) co-transfected into
L929 murine cells in 12 well dishes. Supernatant virus was
recovered, 60 hours post-transfection, and quantified by plaque
assay on HeLa cell monolayers.
Oligonucleotides, viral RNA isolation and characterisation
Viral RNA was extracted from clarified culture supernatant
using a Qiagen RNAeasy Mini kit, reverse transcribed using
Superscript II reverse transcriptase (Invitrogen) and an oligo-dT
primer at 46uC for 50 minutes (mins.) with the reaction terminated
by incubation for 15 mins. at 70uC. PCR amplification of
recombination junctions used template cDNA and appropriate
oligonucleotides as listed in the results section (all oligonucleotides
are listed in Supplementary Table S1) with KOD XL DNA
polymerase (Novagen) used according to the manufacturer’s
protocol. PCR products were sized by agarose gel electrophoresis
and sequenced by the University of Warwick Genomics Facility on
an ABI PRISM 3130xl Genetic Analyser. Sequence analysis used
a combination of Lasergene v.6.0 (DNA*) and Clustal [107] as
appropriate.
Nomenclature for recombinant identification
Reference sequences of poliovirus type 3 Leon (Genbank
#X00925), type 1 Mahoney (Genbank #V01149) or the type 1
Mahoney-derived luciferase-encoding sub-genomic replicon
(pRLucWT). To facilitate definition of junctions defined in clonal
groups of recombinant virus genomes a standardized naming
scheme was used; the 59 and 39 components were numbered with
the last or first nucleotide of the relevant parental genome
(poliovirus type 3 or the type 1 derived sub-genomic replicon). For
reference, the latter consists of a 59 untranslated region (nucleo-
tides 1–742), the luciferase encoding reporter gene (nt. 743–2410)
fused with a short linker to the sequence encoding the last 5 amino
acids of VP1. In this cDNA, nonstructural protein coding region
starts at nt. 2441. In cases where the recombination junction could
not be unambiguously defined – due to sequence identity between
aligned parental genomes – the numbering assumes these
sequences were derived from the parental genome contributing
the 59 portion of the genome. For example, PV33897/PV12737
(recombination group #14C; Figure 3) consists of nucleotides 1-
3897 from PV3 and 2737-polyA from the sub-genomic replicon,
pRLucWT.
Bioinformatic analysis
Mean folding energy differences were calculated essentially as
described previously [67] using a sequence scrambling algorithm
(NDR) that retains compositional features such as the dinucleotide
frequencies of the native sequence as implemented in the SSE
package [108].
Supporting Information
Figure S1 Analysis of heterotypic recombination junctions.
Sequence junctions in the 20 distinct heterotypic recombinant
groups (prefixed #) identified. Upper and lower case sequences
are used to distinguish between those derived from the poliovirus
type 3 CRE-defective genome (pT7/SL3) and poliovirus type 1
sub-genomic replicon (pRLucWT) respectively, with the extent of
the sequence numbered according to the reference genomes (see
Materials and Methods). Sequences derived from the region
encoding the luciferase reporter gene indicated by lower case bold
text. Numbers in parentheses indicate the total number of
independent clones of this sequence obtained. The extent of
additional sequences at the recombination junction are indicated
to the right of each sequence, prefixed with a plus sign. In group
#25A sequences derived from the 59 NCR, nucleotides 447–462
(identical in both parental viruses), are highlighted as white text on
a black background. Calculation of the length of duplicated
sequences in imprecise recombinants. The poliovirus type
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1 sub-genomic replicon (pRLucWT) contains a luciferase reporter
gene in place of the P1 coding region. For Cluster 1 recombinants
it is necessary to determine the length of the additional luciferase
sequences present plus the distance from the start of the P2 coding
region to the position in the aligned poliovirus type 1 and type 3
sequences. For example, #105B consists of nucleotides 1–3371
inclusive of poliovirus type 3, joined to nucleotide 2287 from the
sub-genomic replicon. In the latter the luciferase coding region
extends to nucleotide 2440, with nucleotide 2441 being the start of
the P2 coding region (which corresponds to nucleotide 3386 in the
reference poliovirus type 1 sequence). A numbered alignment of
the P2 coding regions is presented in Figure S6. The position – in
poliovirus type 1 – in this alignment corresponding to nucleotide
3372 of poliovirus type 3 is 3481. Therefore the length of the
additional sequence in #105B is 249 nt, made up of 154 nt. of
luciferase and 95 nt. of the first part of the P2 coding region of
poliovirus type 1. Similarly, the length of additional sequences
present in Cluster 2 imprecise recombinants can be determined
from the alignment presented in Figure S6. For example, #9C
consists of nucleotides 1–3830 of poliovirus type 3 then from
nucleotide 2892 of the poliovirus type 1 sub-genomic replicon to
the end of the genome. Position 2892 corresponds to nucleotide
3827 of the reference poliovirus type 1 sequence. By reference to
the alignment of the P2 region of poliovirus type 1 and type 3
(Figure S6) it can be determined that #9C contains 3 additional
nucleotides at the imprecise junction.
(EPS)
Figure S2 Sequence analysis of cluster 1 (#105B, #53A) and
cluster 2 (#51G, #E1) imprecise recombinants after serial passage
in HeLa cells. Sequences are numbered as indicated in Figure S1.
Sequences with a numeric suffix (i.e. #105B-1 to -3) were
generated after serial passage of virus derived from a constructed
full length #105B cDNA (see text for details).
(EPS)
Figure S3 Ribavirin does not influence the transfection
efficiency of L929 murine cells. Ribavirin at the concentrations
indicated was included in the supernatant media for two hours
pre-transfection and during all subsequent analysis. The poliovirus
type 3 sub-genomic replicon pT7Rep3-L was linearized with Xho I
(which cleaves the cDNA at nt. 6050 within the P3 coding region)
and used as a template for T7 polymerase-mediated in vitro RNA
synthesis. 250 ng of RNA was transfected into L929 cell
monolayers in a 12-well microplate and luciferase activity
quantified (see Materials and Methods) 4 hours post-transfection.
The figures plotted indicate the average of three samples, with the
standard deviation shown as error bars.
(PDF)
Figure S4 A G64S high-fidelity polymerase mutation does not
inhibit poliovirus replication. Murine L929 cells were transfected
with 250 ng of in vitro synthesised RNA generated from pRLucWT
or pRLucWTG64S linearized with Apa I. Encoded luciferase was
quantified at 2.5, 5 and 7.5 hours post-transfection. Error bars
indicate the standard deviation of two independent samples.
(PDF)
Figure S5 Nocodazole does not influence the yield of poliovirus.
Murine L929 cells were chilled and treated with nocodazole (see
Materials and Methods) or treated with carrier (DMSO) alone,
transfected with 250 ng per well (12 well plate) of in vitro
synthesised RNA from a full length infectious cDNA of poliovirus
type 3 and virus yield at 48 hours post-transfection quantified by
plaque assay. Error bars indicate the standard deviation of three
independent samples.
(PDF)
Figure S6 CLUSTAL 2.1 multiple sequence alignment of the P2
and P3 coding regions of poliovirus type 1 and poliovirus type 3. *
indicates identity. Numbering indicates the position in the
reference sequences: Poliovirus type 3 Leon (Genbank
#X00925) and Poliovirus type 1 Mahoney (Genbank #V01149).
(PDF)
Table S1 Oligonucleotide primers used in the study. Degenerate
sequences are indicated using standard IUPAC codes.
(PDF)
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